Cases & Deals

  • Home
  • Practices
  • Cellectis issues €22 million of Common Stock in private placement

Share

Cellectis issues €22 million of Common Stock in private placement

October 2009

Client(s) Cellectis

Jones Day advised Cellectis, a world leader in genome engineering listed on the Alternext market of NYSE Euronext Paris, in the issuance of €22 million (US$32.5 million) of Common Stock in a private placement.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.